↓ Skip to main content

Natalizumab for relapsing remitting multiple sclerosis

Overview of attention for article published in Cochrane database of systematic reviews, October 2011
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (94th percentile)
  • Good Attention Score compared to outputs of the same age and source (79th percentile)

Mentioned by

blogs
1 blog
twitter
13 tweeters
facebook
1 Facebook page

Citations

dimensions_citation
65 Dimensions

Readers on

mendeley
183 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Natalizumab for relapsing remitting multiple sclerosis
Published in
Cochrane database of systematic reviews, October 2011
DOI 10.1002/14651858.cd007621.pub2
Pubmed ID
Authors

Eugenio Pucci, Giorgio Giuliani, Alessandra Solari, Silvana Simi, Silvia Minozzi, Carlo Di Pietrantonj, Ian Galea

Abstract

Natalizumab (NTZ) (Tysabri(®)) is a monoclonal antibody that inhibits leukocyte migration across the blood-brain barrier, thus reducing inflammation in central nervous system, and has been approved worldwide for the treatment of relapsing-remitting multiple sclerosis (RRMS).

Twitter Demographics

The data shown below were collected from the profiles of 13 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 183 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Spain 2 1%
Brazil 2 1%
Italy 1 <1%
Chile 1 <1%
United Kingdom 1 <1%
Sri Lanka 1 <1%
Portugal 1 <1%
Unknown 174 95%

Demographic breakdown

Readers by professional status Count As %
Student > Master 35 19%
Student > Bachelor 24 13%
Student > Ph. D. Student 21 11%
Researcher 20 11%
Student > Doctoral Student 14 8%
Other 37 20%
Unknown 32 17%
Readers by discipline Count As %
Medicine and Dentistry 81 44%
Psychology 13 7%
Agricultural and Biological Sciences 11 6%
Nursing and Health Professions 10 5%
Social Sciences 9 5%
Other 16 9%
Unknown 43 23%

Attention Score in Context

This research output has an Altmetric Attention Score of 21. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 August 2019.
All research outputs
#818,986
of 14,057,722 outputs
Outputs from Cochrane database of systematic reviews
#2,537
of 10,838 outputs
Outputs of similar age
#5,329
of 98,719 outputs
Outputs of similar age from Cochrane database of systematic reviews
#14
of 68 outputs
Altmetric has tracked 14,057,722 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 10,838 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 21.4. This one has done well, scoring higher than 76% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 98,719 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 94% of its contemporaries.
We're also able to compare this research output to 68 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 79% of its contemporaries.